153 related articles for article (PubMed ID: 35981094)
41. Influence of lysosomal protease sensitivity in the immunogenicity of the antitumor biopharmaceutical asparaginase.
Rodrigues MAD; Pimenta MV; Costa IM; Zenatti PP; Migita NA; Yunes JA; Rangel-Yagui CO; de Sá MM; Pessoa A; Costa-Silva TA; Toyama MH; Breyer CA; de Oliveira MA; Santiago VF; Palmisano G; Barbosa CMV; Hebeda CB; Farsky SHP; Monteiro G
Biochem Pharmacol; 2020 Dec; 182():114230. PubMed ID: 32979352
[TBL] [Abstract][Full Text] [Related]
42. Sequencing and characterization of an L-asparaginase gene from a new species of Penicillium section Citrina isolated from Cerrado.
Andrade KCR; Fernandes RA; Pinho DB; de Freitas MM; Filho EXF; Pessoa A; Silva JI; Magalhães PO
Sci Rep; 2021 Sep; 11(1):17861. PubMed ID: 34504186
[TBL] [Abstract][Full Text] [Related]
43. Activity and toxicity of intramuscular 1000 iu/m
Sidhu J; Masurekar AN; Gogoi MP; Fong C; Ioannou T; Lodhi T; Parker C; Liu J; Kirkwood AA; Moorman AV; Das K; Goulden NJ; Vora A; Saha V; Krishnan S
Br J Haematol; 2022 Jul; 198(1):142-150. PubMed ID: 35348200
[TBL] [Abstract][Full Text] [Related]
44. Expanding targets for a metabolic therapy of cancer: L-asparaginase.
Covini D; Tardito S; Bussolati O; Chiarelli LR; Pasquetto MV; Digilio R; Valentini G; Scotti C
Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):4-13. PubMed ID: 21854356
[TBL] [Abstract][Full Text] [Related]
45. The synergism of 6-mercaptopurine plus cytosine arabinoside followed by PEG-asparaginase in human leukemia cell lines (CCRF/CEM/0 and (CCRF/CEM/ara-C/7A) is due to increased cellular apoptosis.
Nandy P; Periclou AP; Avramis VI
Anticancer Res; 1998; 18(2A):727-37. PubMed ID: 9615712
[TBL] [Abstract][Full Text] [Related]
46. Asparaginase activities during intensified treatment with pegylated
Lanvers-Kaminsky C; Niemann A; Eveslage M; Beck J; Köhnke T; Martin S; de Wit M; Spriewald B; Hauspurg H; Hoelzer D; Boos J; Gökbuget N
Leuk Lymphoma; 2020 Jan; 61(1):138-145. PubMed ID: 31480965
[TBL] [Abstract][Full Text] [Related]
47. Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F).
Ardalan N; Akhavan Sepahi A; Khavari-Nejad RA
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1137-1147. PubMed ID: 33906306
[TBL] [Abstract][Full Text] [Related]
48. Asparaginase
Gao C; Ma X; Zhang Z; Lu Q; Ashby CR; Wei L; Chen ZS
Drugs Today (Barc); 2022 Jun; 58(6):261-271. PubMed ID: 35670704
[TBL] [Abstract][Full Text] [Related]
49. Highly efficient Pyrococcus furiosus recombinant L-asparaginase with no glutaminase activity: Expression, purification, functional characterization, and cytotoxicity on THP-1, A549 and Caco-2 cell lines.
Saeed H; Hemida A; El-Nikhely N; Abdel-Fattah M; Shalaby M; Hussein A; Eldoksh A; Ataya F; Aly N; Labrou N; Nematalla H
Int J Biol Macromol; 2020 Aug; 156():812-828. PubMed ID: 32311402
[TBL] [Abstract][Full Text] [Related]
50. Pharmacoanalytical assays of Erwinia asparaginase (erwinase) and pharmacokinetic results in high-risk acute lymphoblastic leukemia (HR ALL) patients: simulations of erwinase population PK-PD models.
Avramis VI; Martin-Aragon S; Avramis EV; Asselin BL
Anticancer Res; 2007; 27(4C):2561-72. PubMed ID: 17695416
[TBL] [Abstract][Full Text] [Related]
51. Drug monitoring of PEG-asparaginase treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
Vieira Pinheiro JP; Lanversa C; Würthwein G; Beier R; Casimiro da Palma J; von Stackelberg A; Boos J
Leuk Lymphoma; 2002 Oct; 43(10):1911-20. PubMed ID: 12481884
[TBL] [Abstract][Full Text] [Related]
52. Pseudomonas aeruginosa recombinant L-asparaginase: Large scale production, purification, and cytotoxicity on THP-1, MDA-MB-231, A549, Caco2 and HCT-116 cell lines.
Saeed H; Hemida A; Abdel-Fattah M; Eldoksh A; Shalaby M; Nematalla H; El-Nikhely N; Elkewedi M
Protein Expr Purif; 2021 May; 181():105820. PubMed ID: 33440252
[TBL] [Abstract][Full Text] [Related]
53. [The feasibility of Erwinia asparaginase for pediatric patients who developed an allergic reaction to E.coli asparaginase during treatment of acute lymphoblastic leukemia].
Takahashi H; Koh K; Kato M; Isobe K; Yasui N; Mori M; Akiyama K; Kikuchi A; Hanada R
Rinsho Ketsueki; 2013 Apr; 54(4):370-7. PubMed ID: 23666219
[TBL] [Abstract][Full Text] [Related]
54. Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines.
Su N; Pan YX; Zhou M; Harvey RC; Hunger SP; Kilberg MS
Pediatr Blood Cancer; 2008 Feb; 50(2):274-9. PubMed ID: 17514734
[TBL] [Abstract][Full Text] [Related]
55. Investigating the gut microbial community and genes in children with differing levels of change in serum asparaginase activity during pegaspargase treatment for acute lymphoblastic leukemia.
Dunn KA; Connors J; Bielawski JP; Nearing JT; Langille MGI; Van Limbergen J; Fernandez CV; MacDonald T; Kulkarni K
Leuk Lymphoma; 2021 Apr; 62(4):927-936. PubMed ID: 33258724
[TBL] [Abstract][Full Text] [Related]
56. An acute lymphoblastic leukemia cell-based preclinical assay revealed functional differences between commercial brands of L-asparaginase administered in Colombia.
Rincón Reyes DF; Padilla Agudelo JL; Pinilla da Silva AI; Ortega Quintero DM; Valencia Libreros DL; Contreras Acosta AD; Gutiérrez Triana JA
Pediatr Blood Cancer; 2023 Apr; 70(4):e30199. PubMed ID: 36633223
[TBL] [Abstract][Full Text] [Related]
57. Expression of a recombinant bacterial L-asparaginase in human cells.
Dantas RC; Caetano LF; Torres ALS; Alves MS; Silva ETMF; Teixeira LPR; Teixeira DC; de Azevedo Moreira R; Fonseca MHG; Gaudêncio Neto S; Martins LT; Furtado GP; Tavares KCS
BMC Res Notes; 2019 Dec; 12(1):794. PubMed ID: 31806048
[TBL] [Abstract][Full Text] [Related]
58. The anticancer effect of PASylated calreticulin-targeting L-ASNase in solid tumor bearing mice with immunogenic cell death-inducing chemotherapy.
Zhang Y; Sultonova RD; You SH; Choi Y; Kim SY; Lee WS; Seong J; Min JJ; Hong Y
Biochem Pharmacol; 2023 Apr; 210():115473. PubMed ID: 36863616
[TBL] [Abstract][Full Text] [Related]
59. L-asparaginase-induced pancreatic injury is associated with an imbalance in plasma amino acid levels.
Minowa K; Suzuki M; Fujimura J; Saito M; Koh K; Kikuchi A; Hanada R; Shimizu T
Drugs R D; 2012 Jun; 12(2):49-55. PubMed ID: 22594522
[TBL] [Abstract][Full Text] [Related]
60. Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.
Ardalan N; Mirzaie S; Sepahi AA; Khavari-Nejad RA
Med Hypotheses; 2018 Mar; 112():7-17. PubMed ID: 29447943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
